Literature DB >> 24992774

Effects of laparoscopic ovarian endometriosis cystectomy combined with postoperative GnRH-a therapy on ovarian reserve, pregnancy, and outcome recurrence.

Xin-Hua Yang, Fei Ji, AiXingZi AiLi, HaNiKeXi TuerXun, Yan He, Yan Ding.   

Abstract

OBJECTIVE: The aim of this study was to investigate the impacts of laparoscopic ovarian endometriosis cystectomy combined with postoperative GnRH-a therapy on ovarian reserve, pregnancy outcome and recurrence.
MATERIALS AND METHODS: This was a prospective control study. The experimental group: 63 patients with combinations of laparoscopic bilateral ovarian endometrial cystectomies and gonadotropin-releasing hormone agonist (GnRH-a) treatment for three months. CONTROL GROUP: 62 patients with laparoscopic bilateral ovarian endometrial cystectomies. Benchmarks: the changes of follicle stimulating hormone (FSH) and FSH/luteinizing hormone (LH), etradiol (E2) in preoperative and postoperative three months or menstrual two to three days, menstrual two to three days after surgery, natural pregnancy, and cyst recurrence in 18th month during postoperative follow-up.
RESULTS: In experimental group after six months, the percentage of returned FSH accounted for 95.3% of normal range, in the control group it was 82.2%, and the difference was significant (p < 0.05). The natural pregnancy rate of preoperative infertility patients (57.1%) was higher than the control (36.8%) (p < 0.05). The recurrence rate of preoperative infertility patients (12.7%) was lower than the control (27.4%) (p < 0.05).
CONCLUSION: After bilateral laparoscopic ovarian endometrial cystectomy, an implement of GnRH-a therapy can improve the postoperative pregnancy rate, which changes with clinical stage and patient age, reduces ovarian recurrence, and its influence on ovarian reserve is lesser.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24992774

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  5 in total

1.  Relation between the testicular sperm assay and sex hormone level in patients with azoospermia induced by mumps.

Authors:  Shuiwen Zhang; Yulin An; Junguo Li; Junhong Guo; Guoping Zhou; Jianhua Li; Ye Xu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

2.  Preventive therapeutic options for postoperative recurrence of ovarian endometrioma: gonadotropin-releasing hormone agonist with or without levonorgestrel intrauterine system insertion.

Authors:  Shi-Yang Zhu; Yu-Shi Wu; Zhi-Yue Gu; Jing Zhang; Shuang-Zheng Jia; Jing-Hua Shi; Yi Dai; Jin-Hua Leng; Xiao-Yan Li
Journal:  Arch Gynecol Obstet       Date:  2020-10-26       Impact factor: 2.344

Review 3.  Reevaluating response and failure of medical treatment of endometriosis: a systematic review.

Authors:  Christian M Becker; William T Gattrell; Kerstin Gude; Sukhbir S Singh
Journal:  Fertil Steril       Date:  2017-07       Impact factor: 7.329

Review 4.  Postoperative hormonal treatment for prevention of endometrioma recurrence after ovarian cystectomy: a systematic review and network meta-analysis.

Authors:  R Wattanayingcharoenchai; S Rattanasiri; C Charakorn; J Attia; A Thakkinstian
Journal:  BJOG       Date:  2020-07-14       Impact factor: 6.531

5.  Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.

Authors:  Ektoras X Georgiou; Pedro Melo; Philip E Baker; Hassan N Sallam; Aydin Arici; Juan A Garcia-Velasco; Ahmed M Abou-Setta; Christian Becker; Ingrid E Granne
Journal:  Cochrane Database Syst Rev       Date:  2019-11-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.